Medical devices, healthcare technology and the business of care
510(k) clearance · K262066

Pleiades Device

My123Baby Medical Limited Dba Boost Fertility · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK262066

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the Pleiades Device, submitted by My123Baby Medical Limited Dba Boost Fertility of Munich, Germany, under 510(k) number K262066. The decision date is 2026-10-30, with the application received 06/22/2026. The listed medical specialty is Obstetrics/Gynecology and the product code is MQK. SESE in the 510(k) pathway denotes clearance as substantially equivalent; it is not a PMA approval.

The source data do not describe the device's components, materials, intended use, or any changed item relative to a predicate, and no summary statement is included. The applicant contact is listed as Daniel Wilson, with Proxima CRO as correspondent. Because the underlying device description and comparison are absent, the technical basis for the equivalence determination cannot be characterized here and remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Oct 30, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262066
Regulatory pathway
510(k) premarket notification
Product code
MQK
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Labware, Assisted Reproduction.

Product code
MQK
FDA device class
2

FDA decision timeline

  1. K262066 received

    Application receipt date recorded by FDA.

  2. K262066 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MQK

Product / regulatory recordCompanyPathwayDecision dateSource
CyperusK262276
Contrario Medical, Inc.510(k) clearanceOct 26, 2026FDA
Fertilis Pty, Ltd.510(k) clearanceOct 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

My123Baby Medical Limited Dba Boost Fertility

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Munich

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records